A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).
Clinical trial NCT02980731 · COMPLETED
Trial details
- NCT number
- NCT02980731
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2021-12-29
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.